查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820204

2025-2033年疟疾诊断市场报告（按技术（显微镜、快速诊断测试（RDT）、分子诊断测试）、最终用途（医院、诊所、诊断中心）和地区）

Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球疟疾诊断市场规模达 8.766 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 14.159 亿美元，2025-2033 年期间的成长率 (CAGR) 为 5.47%。

疟疾诊断是指为检测个体是否感染疟疾而进行的临床检测。疟疾是由受感染的雌性疟蚊叮咬引起的，导致疟原虫进入人体。一些常见症状包括发烧、疲劳、噁心和头痛。疟疾感染的诊断可透过各种快速诊断、显微镜检查和分子诊断检测进行。这些检测采用抗原检测和血清学技术，例如间接免疫萤光法 (IFA) 或酵素连结免疫吸附试验 (ELISA)。这些检测广泛应用于医院、实验室、诊所、研究机构和诊断中心。

疟疾诊断市场趋势：

全球疟疾盛行率的上升是市场前景乐观的关键因素之一。疟疾是一种危及生命的感染，已造成大量人员死亡，尤其是在发展中国家。然而，民众对现有疟疾诊断和治疗方法的认识不断提高，这推动了市场的成长。医疗中心和诊断实验室正在广泛采用显微诊断技术来识别不同阶段的疟原虫并制定合适的治疗方案。此外，各种技术进步，例如用于诊断疟疾的定量白血球层 (QBC) 方法和周边血液抹片技术的开发，也成为其他成长的诱因。同时，用于提高诊断准确性的即时诊断 (POC) 设备的普及也促进了市场的成长。其他因素，包括民众医疗支出能力的提高，以及政府推行的有利于公共卫生的政策，预计将推动市场的成长。

本报告回答的关键问题

  • 全球疟疾诊断市场有多大？ 2025-2033年全球疟疾诊断市场的预期成长率是多少？
  • 推动全球疟疾诊断市场发展的关键因素有哪些？
  • COVID-19 对全球疟疾诊断市场有何影响？
  • 根据技术，全球疟疾诊断市场如何分布？
  • 根据最终用途，全球疟疾诊断市场是如何分布的？
  • 全球疟疾诊断市场的主要地区有哪些？
  • 全球疟疾诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球疟疾诊断市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依技术

  • 显微镜
  • 快速诊断测试（RDT）
  • 分子诊断测试
    • 关键部分
      • 常规PCR
      • 实时PCR（qPCR）

第 7 章：市场区隔：最终用途别

  • 医院
  • 诊所
  • 诊断中心

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Access Bio
    • Beckman Coulter Inc. (Danaher Corporation)
    • bioMerieux SA (Compagnie Merieux Alliance)
    • Bio-Rad Laboratories Inc.
    • Nikon Corporation
    • Novartis AG
    • Olympus Corporation
    • Premier Medical Corporation Pvt. Ltd.
    • Siemens Healthcare GmbH (Siemens AG)
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc
Product Code: SR112025A3896

The global malaria diagnostics market size reached USD 876.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,415.9 Million by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033.

Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

Malaria Diagnostics Market Trends:

The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Technology:

  • Microscopy
  • Rapid Diagnostic Tests (RDTs)
  • Molecular Diagnostic Tests
    • Conventional PCR
    • Real-Time PCR (qPCR)

Breakup by End Use:

  • Hospital
  • Clinics
  • Diagnostic Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.How big is the global malaria diagnostics market?
  • 2.What is the expected growth rate of the global malaria diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global malaria diagnostics market?
  • 4.What has been the impact of COVID-19 on the global malaria diagnostics market?
  • 5.What is the breakup of the global malaria diagnostics market based on the technology?
  • 6.What is the breakup of the global malaria diagnostics market based on the end use?
  • 7.What are the key regions in the global malaria diagnostics market?
  • 8.Who are the key players/companies in the global malaria diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Malaria Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Microscopy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Diagnostic Tests (RDTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostic Tests
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Conventional PCR
      • 6.3.2.2 Real-Time PCR (qPCR)
    • 6.3.3 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospital
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Access Bio
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 bioMerieux SA (Compagnie Merieux Alliance)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bio-Rad Laboratories Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Nikon Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Novartis AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Olympus Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Premier Medical Corporation Pvt. Ltd.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Siemens Healthcare GmbH (Siemens AG)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sysmex Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Thermo Fisher Scientific Inc
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Malaria Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Malaria Diagnostics Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Malaria Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Malaria Diagnostics Market: Breakup by End Use (in %), 2024
  • Figure 6: Global: Malaria Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Malaria Diagnostics (Microscopy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Malaria Diagnostics (Microscopy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Malaria Diagnostics (Hospital) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Malaria Diagnostics (Hospital) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Malaria Diagnostics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Malaria Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Malaria Diagnostics (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Malaria Diagnostics (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: United States: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: United States: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Canada: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Canada: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Asia-Pacific: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Asia-Pacific: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: China: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: China: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Japan: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Japan: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: India: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: India: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: South Korea: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: South Korea: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Australia: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Indonesia: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Indonesia: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Others: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Germany: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Germany: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: France: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: France: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United Kingdom: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United Kingdom: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Italy: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Italy: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Spain: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Spain: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Russia: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Russia: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Latin America: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Latin America: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Brazil: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Brazil: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Mexico: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Mexico: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Middle East and Africa: Malaria Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Middle East and Africa: Malaria Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 67: Middle East and Africa: Malaria Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Global: Malaria Diagnostics Industry: SWOT Analysis
  • Figure 69: Global: Malaria Diagnostics Industry: Value Chain Analysis
  • Figure 70: Global: Malaria Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Malaria Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Malaria Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Malaria Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 4: Global: Malaria Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Malaria Diagnostics Market: Competitive Structure
  • Table 6: Global: Malaria Diagnostics Market: Key Players